Effect of vitamin D supplements on cardiometabolic risk and quality of life in premenopausal women: a randomized control trial
Not Applicable
- Conditions
- Vitamin D deficiencycardiometabolic risk factorsDiet and Nutrition - Other diet and nutrition disordersCardiovascular - HypertensionMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12612000452897
- Lead Sponsor
- niversity of Malaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 320
Inclusion Criteria
Premenopause women age 35 to 50 years old with vitamin D deficiency
Exclusion Criteria
Taking vitamin D supplements > 1000 IU/day, elevated serum calcium > 10.4 mg/dl, elevated serum PTH > 55 pg/ml, pregnant women, participants with granuloma-forming disorder such as tuberculosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in any cardiometabolic risk factors such as hyperlipidaemia measured by fasting blood lipid profile, insulin resistance measure using HOMA-IR and high blood pressure[At baseline, 6 months and 12 months]
- Secondary Outcome Measures
Name Time Method